Search

everythinglearnresearchcommunity

for

Search:↓

Exemestane may protect bones by stimulating osteoblast growth through androgen-related pathways.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Sex hormones might influence bladder cancer development, and aromatase inhibitors could increase risk in postmenopausal women.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Testosterone helps human pancreatic cells increase insulin release.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

New methods to make oxasteroids show promise for medical treatments like osteoporosis and breast cancer.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Letrozole reduces seizures but not brain damage in mice.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

The study found that urine metabolites M1b or M4 are the best indicators of ATD use in horses, with detection possible up to 77 hours in urine and 28 hours in blood.

Patients with HR+/HER2- advanced breast cancer commonly experience fatigue, hair loss, and pain, which significantly affect daily activities.

There are many ways to treat Polycystic Ovary Syndrome, including lifestyle changes, surgery, and various medications, but more research is needed for better treatments.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

Nandrolone and oxandrolone could help treat male health issues like muscle loss and low testosterone.

Estrogens are key for bone growth spurts in both boys and girls and affect growth into adulthood.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

Coumarin derivatives show promise as anti-estrogenic agents for treating breast cancer, with some in clinical trials.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

Drugs for hormone-related conditions might help treat mental disorders but could have serious side effects.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.

Honokiol might help reduce male skin aging by maintaining testosterone levels.